Missy Heidelberg

Missy Heidelberg is the director of bioethics at Takeda Pharmaceuticals and leads the strategy, evaluation, and integration of bioethics into policies, positions, processes, initiatives, and consultations with a specific focus on areas of emerging science and technology. She represents Takeda in multiple industry and professional associations that promote bioethics and ethical behavior in life sciences, remains active in the Columbia University Bioethics Master’s Program, and is a capstone mentor in the Harvard Bioethics Program.